102 related articles for article (PubMed ID: 19228123)
1. Low dose simvastatin induces compositional, structural and dynamic changes in rat skeletal extensor digitorum longus muscle tissue.
Simsek Ozek N; Sara Y; Onur R; Severcan F
Biosci Rep; 2009 Oct; 30(1):41-50. PubMed ID: 19228123
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional characterization of simvastatin-induced myotoxicity in different skeletal muscles.
Simsek Ozek N; Bal IB; Sara Y; Onur R; Severcan F
Biochim Biophys Acta; 2014 Jan; 1840(1):406-15. PubMed ID: 24045089
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and discrimination of simvastatin-induced structural alterations in proteins of different rat tissues by FTIR spectroscopy and neural network analysis.
Garip S; Yapici E; Ozek NS; Severcan M; Severcan F
Analyst; 2010 Dec; 135(12):3233-41. PubMed ID: 21038040
[TBL] [Abstract][Full Text] [Related]
4. Diabetes induces compositional, structural and functional alterations on rat skeletal soleus muscle revealed by FTIR spectroscopy: a comparative study with EDL muscle.
Bozkurt O; Severcan M; Severcan F
Analyst; 2010 Dec; 135(12):3110-9. PubMed ID: 20967384
[TBL] [Abstract][Full Text] [Related]
5. Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers.
Pierno S; De Luca A; Tricarico D; Roselli A; Natuzzi F; Ferrannini E; Laico M; Camerino DC
J Pharmacol Exp Ther; 1995 Dec; 275(3):1490-6. PubMed ID: 8531120
[TBL] [Abstract][Full Text] [Related]
6. Statin or fibrate chronic treatment modifies the proteomic profile of rat skeletal muscle.
Camerino GM; Pellegrino MA; Brocca L; Digennaro C; Camerino DC; Pierno S; Bottinelli R
Biochem Pharmacol; 2011 Apr; 81(8):1054-64. PubMed ID: 21300028
[TBL] [Abstract][Full Text] [Related]
7. Myopathy induced by HMG-CoA reductase inhibitors in rabbits: a pathological, electrophysiological, and biochemical study.
Nakahara K; Kuriyama M; Sonoda Y; Yoshidome H; Nakagawa H; Fujiyama J; Higuchi I; Osame M
Toxicol Appl Pharmacol; 1998 Sep; 152(1):99-106. PubMed ID: 9772205
[TBL] [Abstract][Full Text] [Related]
8. Secondary structure and temperature-induced unfolding and refolding of ribonuclease T1 in aqueous solution. A Fourier transform infrared spectroscopic study.
Fabian H; Schultz C; Naumann D; Landt O; Hahn U; Saenger W
J Mol Biol; 1993 Aug; 232(3):967-81. PubMed ID: 8355280
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.
Smith PF; Eydelloth RS; Grossman SJ; Stubbs RJ; Schwartz MS; Germershausen JI; Vyas KP; Kari PH; MacDonald JS
J Pharmacol Exp Ther; 1991 Jun; 257(3):1225-35. PubMed ID: 1904494
[TBL] [Abstract][Full Text] [Related]
10. Determination of simvastatin-induced changes in bone composition and structure by Fourier transform infrared spectroscopy in rat animal model.
Garip S; Severcan F
J Pharm Biomed Anal; 2010 Aug; 52(4):580-8. PubMed ID: 20185263
[TBL] [Abstract][Full Text] [Related]
11. Rosuvastatin: characterization of induced myopathy in the rat.
Westwood FR; Scott RC; Marsden AM; Bigley A; Randall K
Toxicol Pathol; 2008 Feb; 36(2):345-52. PubMed ID: 18362199
[TBL] [Abstract][Full Text] [Related]
12. Effect of simvastatin on cholesterol metabolism in C2C12 myotubes and HepG2 cells, and consequences for statin-induced myopathy.
Mullen PJ; Lüscher B; Scharnagl H; Krähenbühl S; Brecht K
Biochem Pharmacol; 2010 Apr; 79(8):1200-9. PubMed ID: 20018177
[TBL] [Abstract][Full Text] [Related]
13. Effect of L-carnitine on the skeletal muscle contractility in simvastatin-induced myopathy in rats.
Ghalwash M; Elmasry A; El-Adeeb N
J Basic Clin Physiol Pharmacol; 2018 Sep; 29(5):483-491. PubMed ID: 29584613
[No Abstract] [Full Text] [Related]
14. Effects of myosin heavy chain (MHC) plasticity induced by HMGCoA-reductase inhibition on skeletal muscle functions.
Trapani L; Melli L; Segatto M; Trezza V; Campolongo P; Jozwiak A; Swiezewska E; Pucillo LP; Moreno S; Fanelli F; Linari M; Pallottini V
FASEB J; 2011 Nov; 25(11):4037-47. PubMed ID: 21798954
[TBL] [Abstract][Full Text] [Related]
15. Delineation of myotoxicity induced by 3-hydroxy-3-methylglutaryl CoA reductase inhibitors in human skeletal muscle cells.
Sacher J; Weigl L; Werner M; Szegedi C; Hohenegger M
J Pharmacol Exp Ther; 2005 Sep; 314(3):1032-41. PubMed ID: 15914674
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin induces impairment in skeletal muscle while heart is protected.
Sirvent P; Bordenave S; Vermaelen M; Roels B; Vassort G; Mercier J; Raynaud E; Lacampagne A
Biochem Biophys Res Commun; 2005 Dec; 338(3):1426-34. PubMed ID: 16271704
[TBL] [Abstract][Full Text] [Related]
17. Effect of calcium and phosphatidic acid binding on the C2 domain of PKC alpha as studied by Fourier transform infrared spectroscopy.
García-García J; Corbalán-García S; Gómez-Fernández JC
Biochemistry; 1999 Jul; 38(30):9667-75. PubMed ID: 10423245
[TBL] [Abstract][Full Text] [Related]
18. Lipidomics-based safety biomarkers for lipid-lowering treatments.
Laaksonen R; Jänis MT; Oresic M
Angiology; 2008; 59(2 Suppl):65S-8S. PubMed ID: 18632766
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin treatment induces morphology alterations and apoptosis in murine cochlear neuronal cells.
Park DS; So HS; Lee JH; Park HY; Lee YJ; Cho JH; Yoon KH; Park C; Yun K; Park R
Acta Otolaryngol; 2009 Feb; 129(2):166-74. PubMed ID: 18607908
[TBL] [Abstract][Full Text] [Related]
20. Effects of HMG-CoA reductase inhibitors on excitation-contraction coupling of rat skeletal muscle.
Pierno S; De Luca A; Liantonio A; Camerino C; Conte Camerino D
Eur J Pharmacol; 1999 Jan; 364(1):43-8. PubMed ID: 9920183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
